4//SEC Filing
ADAMIS ANTHONY P 4
Accession 0001562180-23-005502
CIK 0001314102other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:10 PM ET
Size
7.1 KB
Accession
0001562180-23-005502
Insider Transaction Report
Form 4
ADAMIS ANTHONY P
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-23+2,000→ 2,000 total - Exercise/Conversion
Restricted Stock Units
2023-06-23−2,000→ 4,000 totalExercise: $0.00→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]The restricted stock units will vest in three equal annual installments beginning June 23, 2023.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001277479
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 5:10 PM ET
- Size
- 7.1 KB